# Presentation: 692903

## The Neurobiology of Nicotine Dependence and Co-Morbid Psychiatric Disorders

- George F. Koob, Ph.D.
- Athina Markou, Ph.D.
- Department of Neuropharmacology
- The Scripps Research Institute
- La Jolla, California

**Notes:**
KoobG/NP/dia3/031902jh

## Criteria for Substance Dependence (DSM-IV)

**From: Koob GF and Le Moal M, **_**Science**_**, 1997, 278:52-58.**

**Notes:**
016KoobG/NP/dia2c/101797jh
From: Koob and Le Moal, Science, 1997.

## Slide 4

**Notes:**
Old# KoobG/NP/sca2/100998jh
KoobG/NP/sca1/021903pm

## Acute Nicotine Increases Brain Stimulation Reward

**Acute Nicotine Increases Brain ****Stimulation Reward**

**From:  Huston-Lyons D and Kornetsky C,  **_**Pharmacol Bioch Behav**_**, 1992, 41:755-759.**

**Notes:**
Old# KoobG/NP/gra20/032498jh
KoobG/NP/gra8/021803pm

## Slide 6

**Notes:**
KoobG/NP/sca1/043002jh

## Nicotine Self-Administration

**Nicotine Self-Administration**

**Human data adapted from:****	****Henningfield JR, Miyasato K and Jasinski DR, **_**Pharmacol Biochem Behav**_
_**	**_**1983, 19:887-890.**

**Notes:**
Old# KoobG/NP/dia1/050196jh
KoobG/NP/dia1/021803pm

## From:	Watkins SS, Epping-Jordan MP, Koob GF and Markou A, Pharmacol Biochem Behav, 1999, 62:743-751.

**From:****	****Watkins SS, Epping-Jordan MP, Koob GF and Markou A, **_**Pharmacol Biochem Behav**_**, 1999, 62:743-751.**

**Notes:**
Old# KoobG/NP/gra18/032498jh
KoobG/NP/gra7/021803pm

## Effects of DHE on Nicotine Self-Administration in Rats(0.03 mg/injection)

**Effects of DH********E on Nicotine Self-Administration in Rats****(0.03 mg/injection)**

**From:****	****Watkins SS, Epping-Jordan MP, Koob GF and Markou A, **_**Pharmacol Biochem Behav**_**, 1999, 62:743-751**

**Notes:**
Old# KoobG/NP/gra2/041698pm
KoobG/NP/gra1/021803pm

## Key Neurochemical Systems Comprising Brain Drug Reward Circuitry

**Key Neurochemical Systems Comprising Brain Drug Reward Circuitry**

**Notes:**
KoobG/NP/dia1c/021197jh

## Effects of 6-OHDA or Vehicle Infusions into theNucleus Accumbens on Nicotine Self-Administration in Rats

**Effects of 6-OHDA or Vehicle Infusions into the****Nucleus Accumbens on Nicotine Self-Administration in Rats**

**From: Corrigall WA, Franklin FBJ, Coen KM, and Clarke PBS,**_** Psychopharmacology**_**, 1992, 107:285-289.[**

**Notes:**
Old# KoobG/NP/gra1/041698jh
KoobG/NP/gra2/021803pm

## Mechanisms by which Nicotine Interacts

**Nicotine activates nAChRs located on glutamate terminals in the ventral tegmental area (VTA)**

**Nicotine-stimulated glutamate release acts at glutamate receptors located on  VTA dopamine neurons**

**Activation of glutamate receptors stimulates dopamine release into terminal regions, such as the nucleus accumbens**

**Mechanisms by which Nicotine Interacts**
** ****with Dopamine and Glutamate Transmission**

**From:****	****Kelley AE, **_**Nature Med**_**, 2002, 8:477-479.**

## Dependence:An Affective Definition

**“****The notion of dependence on a drug, object, role, activity or any other stimulus-source requires the crucial feature of negative affect experienced in its absence. The degree of dependence can be equated with the amount of this negative affect, which may range from mild discomfort to extreme distress, or it may be equated with the amount of difficulty or effort required to do without the drug, object, etc.”**

**From: Russell MAH, What is dependence? In Edwards G (ed), **_**Drugs and Drug Dependence**_**, Lexington Books, Lexington, MA, 1976, pp. 182-187.**

**Notes:**
KoobG/NP/wor1/010302jh

## Withdrawal from nicotine elicits an aversive 

*Bradycardia*
*Increased appetite*
*Anxiety*
*Depressed Mood*
*Craving*
*Dysphoria*
*Irritability*
*Difficulty concentrating*

- Withdrawal from nicotine elicits an aversive
- behavioral syndrome in humans

## Slide 15

**Notes:**
No number scan.tif

## ICSS Threshold Procedure

**ICSS Threshold Procedure**

**Adapted from: Markou A and Koob GF, **_**Physiol Behav**_**, 1992, 51:111-119.**

**Notes:**
Was: KoobG/NP/dia2/032498jh and KoobG/NP/dia1/041098jh
Became: KoobG/NP/dia1/092502jh

## Spontaneous Nicotine Withdrawal

**Spontaneous Nicotine Withdrawal**

**Adapted from: Epping-Jordan MP, Watkins SS, Koob GF and Markou A, **_**Nature**_**, 1998, 393:76-79.**

**Notes:**
Old# KoobG/NP/gra8/032498jh
KoobG/NP/gra9/021803pm

## DHE-precipitated Nicotine Withdrawal

**DH********E-precipitated Nicotine Withdrawal**

**From: Epping-Jordan MP, Watkins SS, Koob GF and Markou A, **_**Nature**_**, 1998, 393:76-79.**

**Notes:**
Old# KoobG/NP/gra2/041098jh
KoobG/NP/gra3/021803pm

## Brain Reward Function During Acute Withdrawal(0-72 hours)

**Brain Reward Function During Acute Withdrawal****(0-72 hours)**

**Notes:**
KoobG/NP/wor2/040799pm

## Decreases in Extracellular Levels of DopamineDuring Precipitated Nicotine Withdrawal

**Decreases in Extracellular Levels of Dopamine****During Precipitated Nicotine Withdrawal**

**From:****	****Hildebrand BE, Nomikos GG, Hertel P, Schilstrom B and Svensson TH, **_**Brain Res**_**, 1998, 779:214-225.**

**From:****	****Panagis G, Hildebrand BE, Svensson TH and Nomikos GG, **_**Synapse**_**, 2000, 35:15-25.**

**Notes:**
KoobG/NP/dia1/050304jh

## Effects of Nicotine and a Nicotinic Antagonist Injected into the Dorsal Raphe Nucleus on the Social Interaction Test

**Effects of Nicotine and a Nicotinic Antagonist Injected into the Dorsal Raphe Nucleus on the Social Interaction Test**

**From: Cheeta S, Tucci S and File SE, **_**Pharmacol Biochem Behav**_**, 2001, 70:491-496.**

**Notes:**
KoobG/NP/gra1/021203jh

## Nicotine Withdrawal

**Nicotine Withdrawal**

**From:****	****Harrison AA, Liem YTB and Markou A, **_**Neuropsychopharmacology**_**, 2001, 25:55-71.**

**Notes:**
MarkouA/NP/gra4/053001pm

## The mGluII Receptor Antagonist LY341495 Reversed Spontaneous Nicotine Withdrawal

**The mGluII Receptor Antagonist LY341495 Reversed Spontaneous Nicotine Withdrawal**

**From: Kenny PJ, Gasparini F and Markou A, unpublished results.**

**Notes:**
MarkoA/NP/gra3c/040402jh

## Glutamatergic and GABAergic regulation of dopamine transmission in the VTA

- Pre-synaptic Modulation

- Post-synaptic Modulation

**Adapted from: Schoepp DD, **_**J Pharmacol Exp Ther**_**, 2001, 299:12-20.**

## CNS Actions of Corticotropin Releasing Factor (CRF)

**CNS Actions of Corticotropin Releasing Factor ****(CRF)**

**Notes:**
KoobG/NP/dia2c/011000jh

## Neurotransmitter Systems Hypothesized to be Involved in the Motivational Aspects of Nicotine Withdrawal

**Acetylcholine****pedunculopontine tegmental nucleus**
**Dopamine****nucleus accumbens, amygdala**
**Opioid Peptides****nucleus accumbens, amygdala, ventral tegmental area**
**Serotonin****median raphe**
**Glutamate****ventral tegmental area**
**Corticotropin-Releasing Factor (???)**

**Lanca *****et al.*****, 2000**

**Hildebrand *****et al.*****, 1999****Pangis *****et al.*****, 2000**

**Malin *****et al.*****, 1993****Ise *****et al.*****, 2000****Watkins *****et al.*****, 2000**

**Harrison *****et al.*****, 2001****Cheeta *****et al.*****, 2001**

**Kenny *****et al.*****, 2001**

**Notes:**
No# ppt: nicotine neurotransm text

## Depression and Withdrawal from a Variety of Drugsof Abuse are Associated with Altered Function inSeveral Neurotransmitter Systems

**Depression and Withdrawal from a Variety of Drugs****of Abuse are Associated with Altered Function in****Several Neurotransmitter Systems**

**Depression**
**Drug withdrawal**
**	****Psychostimulants**
**	****Opiates**
**	****Ethanol**
**	****Nicotine**

**Ach**

**DA**

**GABA**

**CRF**

**NPY**

**SS**

**Opioids**

**5-HT**

**NE**
**or**

- ?

**Notes:**
retyped

## Hypothetical Anatomical Circuit Underlying Melancholic Depression and Adversity

**Hypothetical Anatomical Circuit Underlying Melancholic Depression and Adversity**

**From: Schulkin J, McEwen BS and Gold PW, **_**Neurosci Biobehav Rev**_**, 1994, 18:385-396.**

**Notes:**
KoobG/NP/dia1/060402jh

## Hypothetical Anatomical Circuit Underlying the “Dark Side” of Drug Dependence

**Hypothetical Anatomical Circuit Underlying the “Dark Side” of Drug Dependence**

**Notes:**
KoobG/NP/dia2c/060402jh

## The Atypical Antidepressant Bupropion Reversed Nicotine Withdrawal

**The Atypical Antidepressant Bupropion Reversed Nicotine Withdrawal**

**Cryan, Bruijnzeel, Skjei & Markou, *****Psychopharmacology*****, 168:347-358, 2003 **

**Notes:**
MarkoA/NP/gra1c/040102jh

## Allostatic Change in Mood State associated with Transition to Drug Addiction

**Allostatic Change in Mood State associated with Transition to Drug Addiction**

**From: Koob GF and Le Moal M, **_**Neuropsychopharmacology**_**, 2001, 24:97-129.**

**Notes:**
043KoobG/NP/dia2c/053100jh

## Potential Substrates in the Extended Amygdala for the Motivational Effects of Drug Dependence

**Potential Substrates in the Extended Amygdala for the Motivational Effects of Drug Dependence**

**Notes:**
KoobG/NP/dia4/102802jh

## Summary and Conclusions

**  **
- Nicotine is readily self-administered by animals and enhances brain reward
- Neurochemical substrates important for the acute reinforcing effects of nicotine include dopamine, GABA, opioid peptides, serotonin, and glutamate systems in the basal forebrain.
- The focus of research to date on the acute reinforcing effects of nicotine has been on specific nicotinic receptor dynamics in the context of glutamate/GABA interactions with dopamine neurons in the ventral tegmental area.
- Development of “motivational” dependence to nicotine is associated with dysregulation of the brain reward system and decreased function in some of the same neurochemical systems involved in negative affect associated with co-morbid psychiatric disorders

## Collaborators

- Athina Markou
- John Cryan
- Mark Epping-Jordan
- Amanda Harrison Paul Kenny

- Laura O’ Dell
- Neil Paterson
- Svetlana Semenova
- Luis Stinus
- Shelly Watkins

- Support from the National Institute on Drug Abuse and National Institute on Mental Health
- Research Grant from Novartis
- Support from the Tobacco Etiology Research Network of the Robert Wood Johnson Foundation
- Support from the Tobacco-Related Disease Research Program, State of California

**Notes:**
KoobG/NP/wor3/032498jh

## Summary and Conclusions (What is unknown)

**  **
- The reward dysregulation of early and late withdrawal from nicotine is hypothesized to result from “allostatic”, rather than homeostatic, changes in the brain reward circuitry.
**   **
- The “dark side” of dependence to nicotine may also involve the recruitment of changes in the brain stress systems including corticotropin releasing factor and/or norepinephrine.
- The  subdivisions of the extended amygdala provide a heuristic framework for integrating the hypothesis that normal motivational function is usurped by chronic drugs of abuse to produce a deficit emotional state associated with addiction.
- Neuropharmacological changes in the circuits of the extended amygdala may persist during protracted withdrawal and provide a motivational basis for vulnerability to co-morbid psychiatric disorders.